An Association Analysis of Circadian Genes in Anxiety Disorders

Biological Psychiatry

Volumn 67, Issue 12, 2010, Pages 1163-1170

  Sipilä, Tessa ^a,b   Kananen, Laura ^a,b   Greco, Dario ^c   Donner, Jonas ^a,b   Silander, Kaisa ^a   Terwilliger, Joseph D ^a,d,e   Auvinen, Petri ^c   Peltonen, Leena ^a,f,g   Lönnqvist, Jouko ^b,h   Pirkola, Sami ^b   Partonen, Timo ^b   Hovatta, Iiris ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Anxiety disorder; circadian gene; gene expression; genetic association; SNP

Indexed keywords

ALCOHOL CONSUMPTION; ANXIETY DISORDER; ARTICLE; CIRCADIAN RHYTHM; COMORBIDITY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL PHOBIA; ADULT; ALCOHOLISM; COMPLICATION; FEMALE; GENETICS; MALE; MIDDLE AGED; PROCEDURES; PSYCHIATRIC DIAGNOSIS;

ADULT; ALCOHOLISM; ANXIETY DISORDERS; CIRCADIAN RHYTHM SIGNALING PEPTIDES AND PROTEINS; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

CIRCADIAN RHYTHM SIGNALING PROTEIN;

EID: 77952886055     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.12.011     Document Type: Article

References (65)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. (2000), American Psychiatric Association, Washington, DC
2. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. 10th ed. (1993), World Health Organization, Geneva
3. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., and Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62 (2005) 617-627
4. Goisman R.M., Goldenberg I., Vasile R.G., and Keller M.B. Comorbidity of anxiety disorders in a multicenter anxiety study. Compr Psychiatry 36 (1995) 303-311
5. Hettema J.M., Prescott C.A., Myers J.M., Neale M.C., and Kendler K.S. The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry 62 (2005) 182-189
6. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. J Am Med Assoc 264 (1990) 2511-2518
7. Pirkola S.P., Isometsa E., Suvisaari J., Aro H., Joukamaa M., Poikolainen K., et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population-Results from the health 2000 study. Soc Psychiatry Psychiatr Epidemiol 40 (2005) 1-10
8. Hettema J.M., Neale M.C., and Kendler K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158 (2001) 1568-1578
9. Hovatta I., and Barlow C. Molecular genetics of anxiety in mice and men. Ann Med 40 (2008) 92-109
10. Mellman T.A., and Uhde T.W. Sleep panic attacks: New clinical findings and theoretical implications. Am J Psychiatry 146 (1989) 1204-1207
11. Stein M.B., Chartier M., and Walker J.R. Sleep in nondepressed patients with panic disorder. I. Systematic assessment of subjective sleep quality and sleep disturbance. Sleep 16 (1993) 724-726
12. Reppert S.M., and Weaver D.R. Coordination of circadian timing in mammals. Nature 418 (2002) 935-941
13. Liu A.C., Lewis W.G., and Kay S.A. Mammalian circadian signaling networks and therapeutic targets. Nat Chem Biol 3 (2007) 630-639
14. Mansour H.A., Monk T.H., and Nimgaonkar V.L. Circadian genes and bipolar disorder. Ann Med 37 (2005) 196-205
15. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., et al. Genetic dissection of psychopathological symptoms: Insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 121 (2003) 35-38
16. Johansson C., Willeit M., Smedh C., Ekholm J., Paunio T., Kieseppa T., et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28 (2003) 734-739
17. Partonen T., Treutlein J., Alpman A., Frank J., Johansson C., Depner M., et al. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann Med 39 (2007) 229-238
18. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11 (2005) 35-42
19. Joe K.H., Kim D.J., Park B.L., Yoon S., Lee H.K., Kim T.S., et al. Genetic association of DRD2 polymorphisms with anxiety scores among alcohol-dependent patients. Biochem Biophys Res Commun 371 (2008) 591-595
20. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 5 (2006) 150-157
21. Rondi-Reig L., Lemaigre Dubreuil Y., Martinou J.C., Delhaye-Bouchaud N., Caston J., and Mariani J. Fear decrease in transgenic mice overexpressing bcl-2 in neurons. Neuroreport 8 (1997) 2429-2432
22. Einat H., Yuan P., and Manji H.K. Increased anxiety-like behaviors and mitochondrial dysfunction in mice with targeted mutation of the Bcl-2 gene: Further support for the involvement of mitochondrial function in anxiety disorders. Behav Brain Res 165 (2005) 172-180
23. Lin B., Kolluri S.K., Lin F., Liu W., Han Y.H., Cao X., et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116 (2004) 527-540
24. Morris M.E., Viswanathan N., Kuhlman S., Davis F.C., and Weitz C.J. A screen for genes induced in the suprachiasmatic nucleus by light. Science 279 (1998) 1544-1547
25. Cheema S.K., Mishra S.K., Rangnekar V.M., Tari A.M., Kumar R., and Lopez-Berestein G. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem 278 (2003) 19995-20005
26. Park S.K., Nguyen M.D., Fischer A., Luke M.P., el Affar B., Dieffenbach P.B., et al. Par-4 links dopamine signaling and depression. Cell 122 (2005) 275-287
27. Yujnovsky I., Hirayama J., Doi M., Borrelli E., and Sassone-Corsi P. Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK: BMAL1. Proc Natl Acad Sci U S A 103 (2006) 6386-6391
28. Borrelli E., Nestler E.J., Allis C.D., and Sassone-Corsi P. Decoding the epigenetic language of neuronal plasticity. Neuron 60 (2008) 961-974
29. Hovatta I., Tennant R.S., Helton R., Marr R.A., Singer O., Redwine J.M., et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438 (2005) 662-666
30. Donner J., Pirkola S., Silander K., Kananen L., Terwilliger J.D., Lonnqvist J., et al. An association analysis of murine anxiety genes in humans implicates novel candidate genes for anxiety disorders. Biol Psychiatry 64 (2008) 672-680
31. Heun R., Papassotiropoulos A., and Ptok U. Subthreshold depressive and anxiety disorders in the elderly. Eur Psychiatry 15 (2000) 173-182
32. Carter R.M., Wittchen H.U., Pfister H., and Kessler R.C. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety 13 (2001) 78-88
33. Hettema J.M., An S.S., Neale M.C., Bukszar J., van den Oord E.J., Kendler K.S., et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 11 (2006) 752-762
34. Hovatta I., Zapala M.A., Broide R.S., Schadt E.E., Libiger O., Schork N.J., et al. DNA variation and brain region-specific expression profiles exhibit different relationships between inbred mouse strains: Implications for eQTL mapping studies. Genome Biol 8 (2007) R25
35. Gentleman R.C., Carey V.J., Bates D.M., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5 (2004) R80
36. Dai M., Wang P., Boyd A.D., Kostov G., Athey B., Jones E.G., et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 33 (2005) e175
37. Maglott D., Ostell J., Pruitt K.D., and Tatusova T. Entrez Gene: Gene-centered information at NCBI. Nucleic Acids Res 35 (2007) D26-D31
38. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 (2003) 249-264
39. Smyth G.K., Michaud J., and Scott H.S. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21 (2005) 2067-2075
40. Carbon S., Ireland A., Mungall C.J., Shu S., Marshall B., Lewis S., et al. Amigo: Online access to ontology and annotation data. Bioinformatics 25 (2009) 288-289
41. Edwards A. Likelihood: Expanded Edition (1992), Johns Hopkins University Press, Baltimore, MD
42. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66 (2008) 87-98
43. Pato C.N., Macciardi F., Pato M.T., Verga M., and Kennedy J.L. Review of the putative association of dopamine D2 receptor and alcoholism: A meta-analysis. Am J Med Genet 48 (1993) 78-82
44. Vawter M.P., Tomita H., Meng F., Bolstad B., Li J., Evans S., et al. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: Implications for brain disorders. Mol Psychiatry 11 (2006) 663-679
45. Rusak B., McNaughton L., Robertson H.A., and Hunt S.P. Circadian variation in photic regulation of immediate-early gene mRNAs in rat suprachiasmatic nucleus cells. Brain Res Mol Brain Res 14 (1992) 124-130
46. Betcheva E.T., Mushiroda T., Takahashi A., Kubo M., Karachanak S.K., Zaharieva I.T., et al. Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. J Hum Genet 54 (2009) 98-107
47. Hanninen K., Katila H., Kampman O., Anttila S., Illi A., Rontu R., et al. Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia. Neurosci Lett 407 (2006) 195-198
48. Ohara K., Nagai M., Tani K., Nakamura Y., Ino A., and Ohara K. Functional polymorphism of -141C ins/del in the dopamine D2 receptor gene promoter and schizophrenia. Psychiatry Res 81 (1998) 117-123
49. Blum K., Noble E.P., Sheridan P.J., Montgomery A., Ritchie T., Jagadeeswaran P., et al. Allelic association of human dopamine D2 receptor gene in alcoholism. J Am Med Assoc 263 (1990) 2055-2060
50. Wacker J., Reuter M., Hennig J., and Stemmler G. Sexually dimorphic link between dopamine D2 receptor gene and neuroticism-anxiety. Neuroreport 16 (2005) 611-614
51. Noble E.P., Blum K., Khalsa M.E., Ritchie T., Montgomery A., Wood R.C., et al. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 33 (1993) 271-285
52. Comings D.E., Muhleman D., Ahn C., Gysin R., and Flanagan S.D. The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug Alcohol Depend 34 (1994) 175-180
53. Comings D.E., Muhleman D., and Gysin R. Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and replication. Biol Psychiatry 40 (1996) 368-372
54. Voisey J., Swagell C.D., Hughes I.P., Morris C.P., van Daal A., Noble E.P., et al. The DRD2 gene 957C > T polymorphism is associated with posttraumatic stress disorder in war veterans. Depress Anxiety 26 (2009) 28-33
55. Schneier F.R., Liebowitz M.R., Abi-Dargham A., Zea-Ponce Y., Lin S.H., and Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 157 (2000) 457-459
56. Sery O., Drtilkova I., Theiner P., Pitelova R., Staif R., Znojil V., et al. Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett 27 (2006) 236-240
57. Schmid C.L., Raehal K.M., and Bohn L.M. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc Natl Acad Sci U S A 105 (2008) 1079-1084
58. Zimmermann P., Wittchen H.U., Hofler M., Pfister H., Kessler R.C., and Lieb R. Primary anxiety disorders and the development of subsequent alcohol use disorders: A 4-year community study of adolescents and young adults. Psychol Med 33 (2003) 1211-1222
59. Sasaki M., Yoshitane H., Du N.H., Okano T., and Fukada Y. Preferential inhibition of BMAL2-CLOCK activity by PER2 reemphasizes its negative role and a positive role of BMAL2 in the circadian transcription. J Biol Chem 284 (2009) 25149-25159
60. Shi J., Wittke-Thompson J.K., Badner J.A., Hattori E., Potash J.B., Willour V.L., et al. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet B Neuropsychiatr Genet 147B (2008) 1047-1055
61. Hatonen T., Forsblom S., Kieseppa T., Lonnqvist J., and Partonen T. Circadian phenotype in patients with the co-morbid alcohol use and bipolar disorders. Alcohol Alcohol 43 (2008) 564-568
62. Schoenhard J.A., Smith L.H., Painter C.A., Eren M., Johnson C.H., and Vaughan D.E. Regulation of the PAI-1 promoter by circadian clock components: Differential activation by BMAL1 and BMAL2. J Mol Cell Cardiol 35 (2003) 473-481
63. Soeda S., Koyanagi S., Kuramoto Y., Kimura M., Oda M., Kozako T., et al. Anti-apoptotic roles of plasminogen activator inhibitor-1 as a neurotrophic factor in the central nervous system. Thromb Haemost 100 (2008) 1014-1020
64. Varilo T., and Peltonen L. Isolates and their potential use in complex gene mapping efforts. Curr Opin Genet Dev 14 (2004) 316-323
65. Cardon L.R., and Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2 (2001) 91-99